• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Small-Molecule Transcription Factor Inhibitors in Oncology

Small-Molecule Transcription Factor Inhibitors in Oncology

Hardcover

Series: Drug Discovery, Book 65

Medical ReferenceChemistry

ISBN10: 1782621458
ISBN13: 9781782621454
Publisher: Royal Society of Chemistry
Published: Sep 6 2018
Pages: 199
Weight: 1.00
Height: 0.60 Width: 6.50 Depth: 9.20
Language: English

Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be reprogrammed, leading to apoptosis or differentiation from the malignant phenotype. As the use of kinase inhibitors is gradually declining, transcription factor inhibition is the next hot topic for oncology research and merits much attention. This book highlights recent progress in the development of small-molecule inhibitors of oncogenic transcription factors. It also presents the evidence that this important protein class can be modulated in a number of ways to develop novel classes of therapeutic agents. The broad range of aspects covered by the book is noteworthy and renders it enormously valuable. This title serves as a unique reference book for postgraduates, academic researchers and practitioners working in the fields of biochemistry, biotechnology, cell and molecular biology and bio-inorganic chemistry.

Also in

Medical Reference